Lipocine (LPCN) Misses Q1 EPS by 1c

Lipocine (NASDAQ: LPCN) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026